FDA Issues Complete Response Letter for Burn Therapy NexoBrid
NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.
Burns
MPR Weekly Dose Podcast 82
This week the FDA approved a regenerative skin tissue therapy and a treatment for advanced mastocytosis, while Novavax’s vaccine for COVID and a novel treatment for MDD show promise, also the FDA issue warning concering hand sanitizers.
StrataGraft Approved to Treat Deep Partial Thickness Burns
The approval was based on data from the 2 randomized clinical studies that assessed StrataGraft in a total of 101 adults with deep partial thickness thermal burns.
